1 |
Tachikawa, E., Kudo, K., Harada, K., Kashimoto, T., Miyate, Y., Kakizaki, A. and Takahashi, E. (1999) Effects of ginseng saponins on responses induced by various receptor stimuli. Eur. J. Pharmacol. 369, 23-32.
DOI
|
2 |
Wang, W., Rayburn, E. R., Hang, J., Zhao, Y., Wang, H. and Zhang, R. (2009) Anti-lung cancer effects of novel ginsenoside 25-OCH3-PPD. Lung Cancer 65, 306-311.
DOI
|
3 |
Yue, P. Y. K., Wong, D. Y. L., Wu, P. K., Leung, P. Y., Mak, N. K., Yeung, H. W., Liu, L., Cai, Z., Jiang, Z.-H., Fan, T. P. D. and Wong, R. N. S. (2006) The angiosuppressive effects of 20(R)- ginsenoside Rg3. Biochem. Pharmacol. 72, 437-445.
DOI
|
4 |
Yun, T. K. (2003) Experimental and epidemiological evidence on nonorgan specifi c cancer preventive effect of Korean ginseng and identifi cation of active compounds. Mutat. Res. 523-524, 63-74.
DOI
|
5 |
Yun, T. K. (2001) Panax ginseng--a non-organ-specifi c cancer preventive? Lancet Oncol. 2, 49-55.
DOI
|
6 |
Qi, L. W., Wang, C. Z. and Yuan, C. S. (2011) Ginsenosides from American ginseng: Chemical and pharmacological diversity. Phytochemistry. 72, 689-699.
DOI
ScienceOn
|
7 |
Sala, F., Mulet, J., Choi, S., Jung, S. Y., Nah, S. Y., Rhim, H., Valor, L. M., Criado, M. and Sala, S. (2002) Effects of ginsenoside Rg2 on human neuronal nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 301, 1052-1059.
DOI
|
8 |
Seo, D. W., Li, H., Qu, C. K., Oh, J., Kim, Y. S., Diaz, T., Wei, B., Han, J. W. and Stetler-Stevenson, W. G. (2006) Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J. Biol. Chem. 281, 3711-3721.
DOI
|
9 |
Seo, D. W., Kim, S. H., Eom, S. H., Yoon, H. J., Cho, Y. R., Kim, P. H., Kim, Y. K., Han, J. W., Diaz, T., Wei, B. Y. and Stetler-Stevenson, W. G. (2008) TIMP-2 disrupts FGF-2-induced downstream signaling pathways. Microvasc. Res. 76, 145-151.
DOI
|
10 |
Seo, D. W., Li, H., Guedez, L., Wingfi eld, P. T., Diaz, T., Salloum, R., Wei, B. Y. and Stetler-Stevenson, W. G. (2003) TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism. Cell. 114, 171-180.
DOI
|
11 |
Sherr, C. J. and Roberts, J. M. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
DOI
|
12 |
Shi, A. W., Wang, X. B., Lu, F. X., Zhu, M. M., Kong, X. Q. and Cao, K. J. (2009) Ginsenoside Rg1 promotes endothelial progenitor cell migration and proliferation. Acta Pharmacol. Sin. 30, 299-306.
DOI
|
13 |
Shibata, S. (2001) Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J. Korean Med. Sci. 16, S28-S37.
DOI
|
14 |
Stetler-Stevenson, W. G., Aznavoorian, S. and Liotta, L. A. (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-573.
DOI
|
15 |
Lee, B. H., Lee, J. H., Lee, S. M., Jeong, S. M., Yoon, I. S., Lee, J. H., Choi, S. H., Pyo, M. K., Rhim, H., Kim, H. C., Jang, C. G., Lee, B. C., Park, C. S. and Nah, S. Y. (2007) Identifi cation of ginsenoside interaction sites in receptors. Neuropharmacology 52, 1139-1150.
DOI
|
16 |
Malumbres, M. and Barbacid, M. (2001) Milestones in cell division : To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer. 1, 222-231.
DOI
|
17 |
Lee, K. Y., Park, J. A., Chung, E., Lee, Y. H., Kim, S. and Lee, S. K. (1996) Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of . Cancer Lett. 110, 193-200.
DOI
|
18 |
Lemmon, M. A. and Schlessinger, J. (2010) Cell signaling by receptor tyrosine kinases. Cell. 141, 1117-1134.
DOI
|
19 |
Leung, K. W., Pon, Y. L., Wong, R. N. S. and Wong, A. S. T. (2006) Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and b-catenin/T-cell factor-dependent pathway in human endothelial cells. J. Biol. Chem. 281, 36280-36288.
DOI
ScienceOn
|
20 |
Park, I. H., Piao, L. Z., Kwon, S. W., Lee, Y. J., Cho, S. Y., Park, M. K. and Park, J. H. (2002) Cytotoxic dammarane glycosides from processed ginseng. Chem. Pharm. Bull. 50, 538-540.
DOI
|
21 |
Park, J. W., Lee, J. C., Ann, S., Seo, D. W., Choi, W. S., Yoo, Y. H., Park, S. K., Choi, J. Y., Um, S. H., Ann, S. H. and Han, J. W. (2011) A fermented ginseng extract, BST204, inhibits proliferation and motility of human colon cancer cells. Biomol. Ther. 19, 211-217.
DOI
|
22 |
Park, T. Y., Park, M. H., Shin, W. C., Rhee, M. H., Seo, D. W., Cho, J. Y. and Kim, H. M. (2008) Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol. Pharm. Bull. 31, 1802-1805.
DOI
ScienceOn
|
23 |
Fenton, T. R. and Gout, I. T. (2011) Functions and regulation of the 70kDa ribosomal S6 kinases. Int. J. Biochem. Cell Biol. 43, 47-59.
DOI
|
24 |
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A. and Dean, D. C. (1999) Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell. 98, 859-869.
DOI
|
25 |
Fuster, J. J., Sanz-Gonzalez, S. M., Moll, U. M. and Andres, V. (2007) Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol. Med. 13, 192-199.
DOI
|
26 |
Han, B. H., Park, M. H., Han, Y. N., Woo, L. K., Sankawa, U., Yahara, S. and Tanaka, O. (1982) Degradation of ginseng saponins under mild acidic conditions. Planta Med. 44, 146-149.
DOI
ScienceOn
|
27 |
Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: The next generation. Cell. 144, 646-674.
DOI
|
28 |
Jin, Y. H., Yoo, K. J., Lee, Y. H. and Lee, S. K. (2000) Caspase 3-mediated cleavage of associated with the cyclin A-cyclindependent kinase 2 complex is a prerequisite for apoptosis in SKHEP- 1 cells. J. Biol. Chem. 275, 30256-30263.
DOI
ScienceOn
|
29 |
Kim, B. H. and Cho, J. Y. (2009) Regulatory role of ginsenoside Rp1, a novel ginsenoside derivative, on CD29-mediated cell adhesion. Planta Med. 75, 316-320.
DOI
ScienceOn
|
30 |
Kumar, A., Kumar, M., Panwar, M., Samarth, R. M., Park, T. Y., Park, M. H. and Kimura, H. (2006) Evaluation of chemopreventive action of Ginsenoside Rp1. Biofactors 26, 29-43.
DOI
|
31 |
Kumar, A., Kumar, M., Park, T. Y., Park, M. H., Takemoto, T., Terado, T., Kitano, M. and Kimura, H. (2009) Molecular mechanisms of ginsenoside Rp1-mediated growth arrest and apoptosis. Int. J. Mol. Med. 24, 381-386.
|
32 |
Attele, A. S., Wu, J. A. and Yuan, C. S. (1999) Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 58, 1685-1693.
DOI
|
33 |
Cho, Y. R., Kim, S. H., Ko, H. Y., Kim, M. D., Choi, S. W. and Seo, D. W. (2011) Sepiapterin inhibits cell proliferation and migration of ovarian cancer cells via down-regulation of -dependent VEGFR-2 expression. Oncol. Rep. 26, 861-867.
|
34 |
Baek, N. I., Kim, D. S., Lee, Y. H., Park, J. D., Lee, C. B. and Kim, S. I. (1996) Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng. Planta. Med. 62, 86-87.
DOI
|
35 |
Bourboulia, D. and Stetler-Stevenson, W. G. (2010) Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin. Cancer Biol. 20, 161-168.
DOI
|
36 |
Cheng, C. C., Yang, S. M., Huang, C. Y., Chen, J. C., Chang, W. M. and Hsu, S. L. (2005) Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother. Pharmacol. 55, 531-540.
DOI
|
37 |
Choi, S., Kim, H. J., Ko, Y. S., Jeong, S. W., Kim, Y. I., Simonds, W. F., Oh, J. W. and Nah, S. Y. (2001) Gaq/11 coupled to mammalian phospholipase C b3-like enzyme mediates the ginsenoside effect on -activated Cl- current in the xenopus oocyte. J. Biol. Chem. 276, 48797-48802.
DOI
|
38 |
Choi, S., Kim, T. W. and Singh, S. (2009) Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by and -dependent inhibition of cyclin-dependent kinases. Pharm. Res. 26, 2280-2288.
DOI
|
39 |
Christofori, G. (2006) New signals from the invasive front. Nature. 441, 444-450.
DOI
|
40 |
Alper, O., Bergmann-Leitner, E. S., Bennett, T. A., Hacker, N. F., Stromberg, K. and Stetler-Stevenson, W. G. (2001) Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells. J. Natl. Cancer Inst. 93, 1375-1384.
DOI
|